A study of safety, tolerability and pharmacokinetics of Y-6 sublingual tablets after single/multiple administration in healthy subjects in China
Latest Information Update: 21 Oct 2024
At a glance
- Drugs Borneol/cilostazol (Primary)
- Indications Cognition disorders; Stroke
- Focus Adverse reactions; Pharmacokinetics
- 17 May 2023 New trial record